1 study on No synthase mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**The endocardial endothelium is a required intermediary for hexarelin's cardiac effects**, which reframes hexarelin as an endothelium-targeting agent rather than a direct myocardial inotrope. For clinicians and resea…